---
figid: PMC4905527__kmco-03-02-1083648-g001
figlink: /pmc/articles/PMC4905527/figure/f0001/
number: F1
caption: hMENA11a delivers survival signals and promotes resistance to PI3K inhibition.
  (A) Overexpression of hMENA11a participates in receptor tyrosine kinase (RTK) and
  survival pathway activation. Specific silencing of hMENA11a inhibits RTK activation
  (i.e., P-HER3), favoring cell apoptosis. (B) Treatment of HER2+ breast cancer cell
  lines with PI3K inhibitors determines FOXO3a nuclear translocation and HER3 upregulation,
  a mechanism involved in therapy resistance. PI3K inhibitors induce phosphorylation
  of hMENA11a. In cells that are specifically silenced for hMENA11a and treated with
  PI3K inhibitors, FOXO3a is sequestered in the cytoplasm and does not shuttle into
  the nucleus and HER3 is not upregulated, rendering cells sensitive to therapy. BIM,
  Bcl2-interacting mediator of cell death; CASP9, caspase 9; FOXO3a, Forkhead box
  O3a; hMENA, human MENA; P-HER3, phospho-human epidermal growth factor receptor 3;
  RTK, receptor tyrosine kinase; P-AKT, phospho-protein kinase B; PARP, poly (ADP-ribose)
  polymerase; PI3K, phosphatidylinositol-3-kinase.
pmcid: PMC4905527
papertitle: hMENA11a, a hMENA isoform sending survival signals.
reftext: Paola Trono, et al. Mol Cell Oncol. 2016 Mar;3(2):e1083648.
pmc_ranked_result_index: '166308'
pathway_score: 0.9347577
filename: kmco-03-02-1083648-g001.jpg
figtitle: hMENA11a delivers survival signals and promotes resistance to PI3K inhibition
year: '2016'
organisms:
- Homo sapiens
ndex: a8d0025c-de91-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4905527__kmco-03-02-1083648-g001.html
  '@type': Dataset
  description: hMENA11a delivers survival signals and promotes resistance to PI3K
    inhibition. (A) Overexpression of hMENA11a participates in receptor tyrosine kinase
    (RTK) and survival pathway activation. Specific silencing of hMENA11a inhibits
    RTK activation (i.e., P-HER3), favoring cell apoptosis. (B) Treatment of HER2+
    breast cancer cell lines with PI3K inhibitors determines FOXO3a nuclear translocation
    and HER3 upregulation, a mechanism involved in therapy resistance. PI3K inhibitors
    induce phosphorylation of hMENA11a. In cells that are specifically silenced for
    hMENA11a and treated with PI3K inhibitors, FOXO3a is sequestered in the cytoplasm
    and does not shuttle into the nucleus and HER3 is not upregulated, rendering cells
    sensitive to therapy. BIM, Bcl2-interacting mediator of cell death; CASP9, caspase
    9; FOXO3a, Forkhead box O3a; hMENA, human MENA; P-HER3, phospho-human epidermal
    growth factor receptor 3; RTK, receptor tyrosine kinase; P-AKT, phospho-protein
    kinase B; PARP, poly (ADP-ribose) polymerase; PI3K, phosphatidylinositol-3-kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R3
  - ERBB3
  - PARP14
  - PIK3CD
  - AKT3
  - AKT2
  - PIK3R6
  - PIK3CG
  - CASP9
  - PARP15
  - PARP16
  - PARP6
  - AKT1
  - PIK3R4
  - BIRC5
  - PARP2
  - PARP1
  - PARP12
  - TNKS
  - PARP10
  - PIK3CB
  - PIK3R5
  - PARP4
  - PIK3CA
  - TNKS2
  - PARP11
  - PARP8
  - TIPARP
  - PARP3
  - PARP9
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: P-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: P-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CASP9
  symbol: CASP9
  source: hgnc_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: P-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: SURVIVIN
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
chemicals: []
diseases: []
figid_alias: PMC4905527__F1
redirect_from: /figures/PMC4905527__F1
figtype: Figure
---
